Literature DB >> 17028863

Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma.

Seppo Rönkkö1, Petri Rekonen, Kai Kaarniranta, Tuomo Puustjärvi, Markku Teräsvirta, Hannu Uusitalo.   

Abstract

BACKGROUND: In glaucoma, extensive pathological changes occur in the trabecular meshwork (TM) and juxtacanalicular tissue of the chamber angle. Aqueous humor drainage is disturbed due to the accumulation of extracellular matrix (ECM) material in the outflow system. Matrix metalloproteinases (MMPs) remodel ECM material and, thus, they may have a role in regulating outflow facility and intraocular pressure (IOP). This study examined the expression of MMPs and tissue inhibitors of MMPs (TIMPs) in the chamber angle of normal eyes and in primary open-angle glaucoma (POAG) and in exfoliation glaucoma (ExG).
METHODS: TM tissues were isolated from healthy donor eyes for corneal transplantation. Specimens of the inner wall of Schlemm's canal and the juxtacanalicular tissue were collected from patients with POAG or ExG during deep sclerectomy operation. Monoclonal antibodies against MMPs (MMP-1, -2, -3, and -9) and antibodies against TIMPs (TIMP-1, -2, and -3) were used for immunohistochemical staining.
RESULTS: Immunoreactivity for MMP-2, TIMP-2, or TIMP-3 was observed in human normal TM and in the inner wall of Schlemm's canal. In general, immunoreactions for all of the tested MMPs were more intense in POAG samples than in ExG samples or in the control group. The only exception was the MMP-2 level, which was the highest in the control group. The staining intensity of MMP-1 or MMP-3 was significantly higher in POAG when compared to ExG. TIMP-1 was significantly increased in POAG compared with ExG and there were no marked differences in the levels of TIMP-2 or TIMP-3 between POAG and ExG. The ratios of MMP-1/TIMP-1 and MMP(1+2+3+9) and TIMP(1+2+3) were significantly higher in samples from POAG compared to those of ExG.
CONCLUSIONS: Our results reveal an expression imbalance between MMPs and their endogenous tissue inhibitors in tissue samples from patients with POAG and ExG. Differences in immunohistochemical reactions reflect discrete local pathogenic mechanisms involved in POAG and ExG. With respect to the proposed role of MMPs in the remodeling of ECM material, this may point to a weaker reactivity to the accumulation of ECM material in TM in ExG than POAG eyes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028863     DOI: 10.1007/s00417-006-0440-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  36 in total

Review 1.  MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology.

Authors:  Jeremy M Sivak; M Elizabeth Fini
Journal:  Prog Retin Eye Res       Date:  2002-01       Impact factor: 21.198

Review 2.  Matrix metalloproteinases: pathways of induction by bioactive molecules.

Authors:  Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

3.  A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.

Authors:  Y Okada; H Nagase; E D Harris
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

4.  Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma.

Authors:  Marko Määttä; Taina Tervahartiala; Mika Harju; Juhani Airaksinen; Helena Autio-Harmainen; Timo Sorsa
Journal:  J Glaucoma       Date:  2005-02       Impact factor: 2.503

Review 5.  Glaucoma.

Authors:  A L Coleman
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

6.  Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma.

Authors:  A G Konstas; W C Stewart; G A Stroman; C S Sine
Journal:  Ophthalmic Surg Lasers       Date:  1997-02

7.  Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.

Authors:  G Murphy; R Ward; R M Hembry; J J Reynolds; K Kühn; K Tryggvason
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

8.  Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.

Authors:  J P Alexander; J R Samples; E M Van Buskirk; T S Acott
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-01       Impact factor: 4.799

Review 9.  Why is glaucoma associated with exfoliation syndrome?

Authors:  Robert Ritch; Ursula Schlötzer-Schrehardt; Anastasios G P Konstas
Journal:  Prog Retin Eye Res       Date:  2003-05       Impact factor: 21.198

10.  Prevalence of exfoliation syndrome in Finland.

Authors:  U Krause; H I Alanko; J Kärnä; R Miettinen; T Larmi; E Jaanio; O I Ollila; J Takala
Journal:  Acta Ophthalmol Suppl       Date:  1988
View more
  34 in total

1.  Differentially expressed microRNAs in the aqueous humor of patients with exfoliation glaucoma or primary open-angle glaucoma.

Authors:  Michelle D Drewry; Pratap Challa; John G Kuchtey; Iris Navarro; Inas Helwa; Yanzhong Hu; Hongmei Mu; W Daniel Stamer; Rachel W Kuchtey; Yutao Liu
Journal:  Hum Mol Genet       Date:  2018-04-01       Impact factor: 6.150

2.  Fluorescent protein-labeled glucocorticoid receptor alpha isoform trafficking in cultured human trabecular meshwork cells.

Authors:  Adnan Dibas; Ming Jiang; Rafal Fudala; Ignacy Gryczynski; Zygmunt Gryczynski; Abbot F Clark; Thomas Yorio
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

Review 3.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

4.  Biomarkers of primary open-angle glaucoma.

Authors:  Paul A Knepper; John R Samples; Beatrice Yjt Yue
Journal:  Expert Rev Ophthalmol       Date:  2010-12

5.  Changes of TGF-β2, MMP-2, and TIMP-2 levels in the vitreous of patients with high myopia.

Authors:  Hong Zhuang; Rong Zhang; Qinmeng Shu; Rui Jiang; Qing Chang; Xin Huang; Chunhui Jiang; Gezhi Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-13       Impact factor: 3.117

6.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

7.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

8.  The association between matrix metalloprotease-9 gene polymorphisms and primary angle-closure glaucoma in a Chinese Han population.

Authors:  Xiao-Jin Gao; Sheng-Ping Hou; Ping-Hua Li
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

9.  PRDX6 attenuates oxidative stress- and TGFbeta-induced abnormalities of human trabecular meshwork cells.

Authors:  Nigar Fatma; Eri Kubo; Carol B Toris; W D Stamer; Carl B Camras; Dhirendra P Singh
Journal:  Free Radic Res       Date:  2009-07-01

Review 10.  Extracellular matrix turnover and outflow resistance.

Authors:  Kate E Keller; Mini Aga; John M Bradley; Mary J Kelley; Ted S Acott
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.